Stay updated on Immunotherapy With BCMA CAR-T Cells in BCMA+ Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Immunotherapy With BCMA CAR-T Cells in BCMA+ Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunotherapy With BCMA CAR-T Cells in BCMA+ Multiple Myeloma Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-05-01T05:59:09.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The webpage has been updated to include new information about a clinical trial for Recurrent Plasma Cell Myeloma, including details about collaborators and registry identifiers, while significant content regarding the trial's objectives and methodology has been removed.
    Difference
    40%
    Check dated 2025-04-16T15:03:57.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T10:39:22.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T23:43:15.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1.0%
    Check dated 2025-02-24T22:11:45.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    1.0%
    Check dated 2025-02-10T14:40:11.000Z thumbnail image

Stay in the know with updates to Immunotherapy With BCMA CAR-T Cells in BCMA+ Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunotherapy With BCMA CAR-T Cells in BCMA+ Multiple Myeloma Clinical Trial page.